Published in BMJ on October 15, 2005
What is "quality of evidence" and why is it important to clinicians? BMJ (2008) 6.99
Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ (2011) 6.89
Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Med Decis Making (2012) 3.36
Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews. BMJ (2009) 3.18
Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ (2012) 3.15
Steroids and bronchodilators for acute bronchiolitis in the first two years of life: systematic review and meta-analysis. BMJ (2011) 3.00
Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies. Res Synth Methods (2012) 2.64
Exercise for lower limb osteoarthritis: systematic review incorporating trial sequential analysis and network meta-analysis. BMJ (2013) 2.62
Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression. Res Synth Methods (2012) 2.57
Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials. Med Decis Making (2013) 2.39
Single dose oral analgesics for acute postoperative pain in adults. Cochrane Database Syst Rev (2011) 2.20
Acupuncture and other physical treatments for the relief of pain due to osteoarthritis of the knee: network meta-analysis. Osteoarthritis Cartilage (2013) 2.10
Industry sponsorship bias in research findings: a network meta-analysis of LDL cholesterol reduction in randomised trials of statins. BMJ (2014) 2.09
Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis. BMJ (2008) 2.09
Development of a transparent interactive decision interrogator to facilitate the decision-making process in health care. Value Health (2011) 2.05
Network meta-analysis-highly attractive but more methodological research is needed. BMC Med (2011) 2.02
Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis. PLoS Med (2009) 1.95
Network meta-analysis of margin threshold for women with ductal carcinoma in situ. J Natl Cancer Inst (2012) 1.87
Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study. BMJ (2011) 1.86
Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. CMAJ (2009) 1.73
Evaluation of inconsistency in networks of interventions. Int J Epidemiol (2013) 1.72
Comparative effectiveness of long term drug treatment strategies to prevent asthma exacerbations: network meta-analysis. BMJ (2014) 1.67
Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers. BMC Med (2013) 1.54
Treatments for relapsing-remitting multiple sclerosis: summarising current information by network meta-analysis. Eur J Clin Pharmacol (2011) 1.48
Indirect comparison of etanercept, infliximab, and adalimumab for psoriatic arthritis: mixed treatment comparison using placebo as common comparator. Clin Rheumatol (2011) 1.42
Second-line therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a systematic review and mixed-treatment comparison meta-analysis. Open Med (2011) 1.41
Characteristics and knowledge synthesis approach for 456 network meta-analyses: a scoping review. BMC Med (2017) 1.39
Evidence synthesis as the key to more coherent and efficient research. BMC Med Res Methodol (2009) 1.39
Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis. BMC Med (2009) 1.37
A meta-analytic review of the psychosocial adjustment of youth with inflammatory bowel disease. J Pediatr Psychol (2010) 1.30
Evaluating the quality of evidence from a network meta-analysis. PLoS One (2014) 1.26
Systematic review and meta-analysis: techniques and a guide for the academic surgeon. Ann Cardiothorac Surg (2015) 1.26
Treatment of ureteral and renal stones: a systematic review and meta-analysis of randomized, controlled trials. J Urol (2012) 1.24
Ministernotomy or minithoracotomy for minimally invasive aortic valve replacement: a Bayesian network meta-analysis. Ann Cardiothorac Surg (2015) 1.22
Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorial. BMC Med Res Methodol (2010) 1.21
A design-by-treatment interaction model for network meta-analysis with random inconsistency effects. Stat Med (2014) 1.21
Network meta-analysis of survival data with fractional polynomials. BMC Med Res Methodol (2011) 1.18
Evidence synthesis for decision making 7: a reviewer's checklist. Med Decis Making (2013) 1.16
Outcomes in Cochrane systematic reviews addressing four common eye conditions: an evaluation of completeness and comparability. PLoS One (2014) 1.15
Incorporating multiple interventions in meta-analysis: an evaluation of the mixed treatment comparison with the adjusted indirect comparison. Trials (2009) 1.15
Multiple treatment comparisons in epilepsy monotherapy trials. Trials (2007) 1.14
The quality of reporting methods and results in network meta-analyses: an overview of reviews and suggestions for improvement. PLoS One (2014) 1.13
Comparative efficacy of long-acting bronchodilators for COPD: a network meta-analysis. Respir Res (2013) 1.12
Wasted research when systematic reviews fail to provide a complete and up-to-date evidence synthesis: the example of lung cancer. BMC Med (2016) 1.10
Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol (2012) 1.09
Efficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysis. Ann Fam Med (2015) 1.09
Meta-regression models to address heterogeneity and inconsistency in network meta-analysis of survival outcomes. BMC Med Res Methodol (2012) 1.08
Sharing individual participant data from clinical trials: an opinion survey regarding the establishment of a central repository. PLoS One (2014) 1.07
Efficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: a study level and a patient level network meta-analysis. BMC Pulm Med (2012) 1.04
Evidence-based surgery: barriers, solutions, and the role of evidence synthesis. World J Surg (2012) 1.02
Polyethylene glycol vs. sodium phosphate for bowel preparation: a treatment arm meta-analysis of randomized controlled trials. BMC Gastroenterol (2011) 1.01
Network meta-analysis of randomized clinical trials: reporting the proper summaries. Clin Trials (2013) 1.00
The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women. BMC Musculoskelet Disord (2011) 0.99
Corticosteroid and antiviral therapy for Bell's palsy: a network meta-analysis. BMC Neurol (2011) 0.99
Comparative efficacy of indacaterol 150 μg and 300 μg versus fixed-dose combinations of formoterol + budesonide or salmeterol + fluticasone for the treatment of chronic obstructive pulmonary disease--a network meta-analysis. Int J Chron Obstruct Pulmon Dis (2011) 0.97
The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials. Support Care Cancer (2015) 0.96
Labour induction with prostaglandins: a systematic review and network meta-analysis. BMJ (2015) 0.96
Second generation endometrial ablation techniques for heavy menstrual bleeding: network meta-analysis. BMJ (2012) 0.96
Individual patient data network meta-analysis of mortality effects of implantable cardiac devices. Heart (2015) 0.95
Methods used to conduct and report Bayesian mixed treatment comparisons published in the medical literature: a systematic review. BMJ Open (2013) 0.94
Absolute or relative effects? Arm-based synthesis of trial data. Res Synth Methods (2015) 0.94
A process for assessing the feasibility of a network meta-analysis: a case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer. BMC Med (2014) 0.94
Choice of therapy in patients with type 2 diabetes inadequately controlled with metformin and a sulphonylurea: a systematic review and mixed-treatment comparison meta-analysis. Open Med (2012) 0.93
A Bayesian missing data framework for generalized multiple outcome mixed treatment comparisons. Res Synth Methods (2015) 0.93
Efficacy of anti-VEGF and laser photocoagulation in the treatment of visual impairment due to diabetic macular edema: a systematic review and network meta-analysis. PLoS One (2014) 0.93
Requirements for benefit assessment in Germany and England - overview and comparison. Health Econ Rev (2014) 0.93
'Lost in translation': accounting for between-country differences in the analysis of multinational cost-effectiveness data. Pharmacoeconomics (2006) 0.93
The effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: systematic review, network meta-analysis and health economic evaluation. BMC Pharmacol Toxicol (2014) 0.92
Comparative efficacy of aclidinium versus glycopyrronium and tiotropium, as maintenance treatment of moderate to severe COPD patients: a systematic review and network meta-analysis. Int J Chron Obstruct Pulmon Dis (2013) 0.92
Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis. BMJ Open (2014) 0.90
The beneficial effect of alpha-blockers for ureteral stent-related discomfort: systematic review and network meta-analysis for alfuzosin versus tamsulosin versus placebo. BMC Urol (2015) 0.89
No role for initial severity on the efficacy of antidepressants: results of a multi-meta-analysis. Ann Gen Psychiatry (2013) 0.89
Effect of combination therapy on joint destruction in rheumatoid arthritis: a network meta-analysis of randomized controlled trials. PLoS One (2014) 0.89
Network meta-analysis for comparing treatment effects of multiple interventions: an introduction. Rheumatol Int (2014) 0.88
Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analysis. Health Qual Life Outcomes (2014) 0.88
Mechanical ventilation strategies for intensive care unit patients without acute lung injury or acute respiratory distress syndrome: a systematic review and network meta-analysis. Crit Care (2016) 0.87
Comparative efficacy and acceptability of antidepressants in Parkinson's disease: a network meta-analysis. PLoS One (2013) 0.87
Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis. Arthritis Res Ther (2015) 0.87
The relative efficacy of imatinib, dasatinib and nilotinib for newly diagnosed chronic myeloid leukemia: a systematic review and network meta-analysis. Exp Hematol Oncol (2013) 0.87
Overall similarity and consistency assessment scores are not sufficiently accurate for predicting discrepancy between direct and indirect comparison estimates. J Clin Epidemiol (2012) 0.86
The attractiveness of network meta-analysis: a comprehensive systematic and narrative review. Heart Lung Vessel (2015) 0.85
Automated generation of node-splitting models for assessment of inconsistency in network meta-analysis. Res Synth Methods (2015) 0.85
Systematic literature review and network meta-analysis comparing bone-targeted agents for the prevention of skeletal-related events in cancer patients with bone metastasis. Oncologist (2015) 0.85
A network meta-analysis of the relative efficacy of treatments for actinic keratosis of the face or scalp in Europe. PLoS One (2014) 0.85
Geometry of the randomized evidence for treatments of pulmonary hypertension. Cardiovasc Ther (2013) 0.85
Randomized studies are needed to assess the true role of self-monitoring of blood glucose in noninsulin-treated type 2 diabetes. J Diabetes Sci Technol (2007) 0.84
Control strategies to prevent total hip replacement-related infections: a systematic review and mixed treatment comparison. BMJ Open (2014) 0.84
Comparing bona fide psychotherapies of depression in adults with two meta-analytical approaches. PLoS One (2013) 0.84
Relative survival benefit and morbidity with fluids in severe sepsis - a network meta-analysis of alternative therapies. Curr Drug Saf (2013) 0.84
Chemotherapy for patients with gastric cancer after complete resection: a network meta-analysis. World J Gastroenterol (2014) 0.84
Impact of GLP-1 receptor agonists on major gastrointestinal disorders for type 2 diabetes mellitus: a mixed treatment comparison meta-analysis. Exp Diabetes Res (2012) 0.84
Treatment comparison in rheumatoid arthritis: head-to-head trials and innovative study designs. Biomed Res Int (2014) 0.84
Gastrointestinal adverse events of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis. Diabetes Technol Ther (2015) 0.84
Bias in identification of the best treatment in a Bayesian network meta-analysis for binary outcome: a simulation study. Clin Epidemiol (2014) 0.83
A systematic review and mixed-treatment comparison of dapagliflozin with existing anti-diabetes treatments for those with type 2 diabetes mellitus inadequately controlled by sulfonylurea monotherapy. Diabetol Metab Syndr (2014) 0.83
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet (2003) 19.90
Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ (1999) 14.34
Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med (2004) 9.10
The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol (1997) 9.01
Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Stat Med (2002) 8.72
Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA (2003) 7.42
In pursuit of quality: the National Institute for Clinical Excellence. Lancet (1999) 7.20
Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ (2003) 6.61
Network meta-analysis for indirect treatment comparisons. Stat Med (2002) 6.32
Borrowing strength from external trials in a meta-analysis. Stat Med (1996) 4.23
Methods in health service research. An introduction to bayesian methods in health technology assessment. BMJ (1999) 3.12
Investigating underlying risk as a source of heterogeneity in meta-analysis. Stat Med (1997) 2.43
Meta-analysis of multitreatment studies. Med Decis Making (1998) 2.09
Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Health Technol Assess (2005) 1.64
Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation. Health Technol Assess (2003) 1.46
A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder. Health Technol Assess (2004) 1.25
Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.09
Primary angioplasty or thrombolysis for acute myocardial infarction? Lancet (2003) 1.05
Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med (2004) 9.10
Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet (1992) 7.56
Evaluation of networks of randomized trials. Stat Methods Med Res (2007) 4.70
Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies. BMJ (2001) 4.15
Checking consistency in mixed treatment comparison meta-analysis. Stat Med (2010) 4.15
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol (2010) 4.10
A systematic review of the use of opioids in the management of dyspnoea. Thorax (2002) 4.10
The interpretation of random-effects meta-analysis in decision models. Med Decis Making (2005) 3.98
Infants born to mothers seropositive for human immunodeficiency virus. Preliminary findings from a multicentre European study. Lancet (1987) 3.95
Epidemiology and detection of HIV-1 among pregnant women in the United Kingdom: results from national surveillance 1988-96. BMJ (1998) 3.85
Factors affecting uptake of antenatal HIV testing in London: results of a multicentre study. BMJ (1998) 3.72
Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Med Decis Making (2012) 3.36
Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol (2012) 2.87
Vertical transmission rates for HIV in the British Isles: estimates based on surveillance data. BMJ (1999) 2.68
Topical fluoride (toothpastes, mouthrinses, gels or varnishes) for preventing dental caries in children and adolescents. Cochrane Database Syst Rev (2003) 2.56
Use of anonymous newborn serosurveys to evaluate antenatal HIV screening programmes. J Med Screen (1994) 2.45
Evidence synthesis for decision making 3: heterogeneity--subgroups, meta-regression, bias, and bias-adjustment. Med Decis Making (2013) 2.43
Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials. Med Decis Making (2013) 2.39
Systematic review of prevalence studies of autism spectrum disorders. Arch Dis Child (2005) 2.30
Use of indirect and mixed treatment comparisons for technology assessment. Pharmacoeconomics (2008) 2.15
Prevalence of maternal HIV infection based on unlinked anonymous testing of newborn babies. Lancet (1990) 2.11
Combinations of topical fluoride (toothpastes, mouthrinses, gels, varnishes) versus single topical fluoride for preventing dental caries in children and adolescents. Cochrane Database Syst Rev (2004) 2.04
Assessment of regression-based methods to adjust for publication bias through a comprehensive simulation study. BMC Med Res Methodol (2009) 2.01
Antigen detection, virus culture, polymerase chain reaction, and in vitro antibody production in the diagnosis of vertically transmitted HIV-1 infection. AIDS (1991) 1.97
Prevention of mother-to-child transmission of HIV-1 infection: alternative strategies and their cost-effectiveness. AIDS (1998) 1.94
Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation. Stat Med (2009) 1.90
Antenatal testing for human immunodeficiency virus. Results from the Royal College of Obstetricians and Gynaecologists' National Study of HIV Infection in Pregnancy. Lancet (1989) 1.90
Intelligence and quality of dietary treatment in phenylketonuria. Arch Dis Child (1990) 1.89
Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials. Eur J Prev Cardiol (2013) 1.88
Antenatal and neonatal haemoglobinopathy screening in the UK: review and economic analysis. Health Technol Assess (1999) 1.80
Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France. Int J Epidemiol (2001) 1.78
Covariate heterogeneity in meta-analysis: criteria for deciding between meta-regression and individual patient data. Stat Med (2007) 1.74
Study designs to detect sponsorship and other biases in systematic reviews. J Clin Epidemiol (2010) 1.65
Estimation of markov chain transition probabilities and rates from fully and partially observed data: uncertainty propagation, evidence synthesis, and model calibration. Med Decis Making (2005) 1.56
Descriptive survey of antenatal HIV testing in London: policy, uptake, and detection. BMJ (1996) 1.55
Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol (2008) 1.53
Mixed treatment comparison analysis provides internally coherent treatment effect estimates based on overviews of reviews and can reveal inconsistency. J Clin Epidemiol (2010) 1.50
Probabilistic sensitivity analysis for decision trees with multiple branches: use of the Dirichlet distribution in a Bayesian framework. Med Decis Making (2003) 1.46
Lifetime treatment costs of beta-thalassaemia major. Clin Lab Haematol (1999) 1.46
A review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection. Int J Epidemiol (1998) 1.44
Changing prevalence of juvenile-onset diabetes mellitus. Lancet (1988) 1.30
Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model. Am J Epidemiol (2013) 1.29
Interventions for treating hallux valgus (abductovalgus) and bunions. Cochrane Database Syst Rev (2004) 1.28
Evaluation of five commercial assays for screening antenatal sera for antibodies to Toxoplasma gondii. J Clin Pathol (1992) 1.27
Antenatal screening for haemoglobinopathies in primary care: a cohort study and cluster randomised trial to inform a simulation model. The Screening for Haemoglobinopathies in First Trimester (SHIFT) trial. Health Technol Assess (2010) 1.26
Meta-analysis of mixed treatment comparisons at multiple follow-up times. Stat Med (2007) 1.25
Evidence synthesis for decision making 5: the baseline natural history model. Med Decis Making (2013) 1.25
Fluoride mouthrinses for preventing dental caries in children and adolescents. Cochrane Database Syst Rev (2003) 1.23
Insights into the rise in HIV infections, 2001 to 2008: a Bayesian synthesis of prevalence evidence. AIDS (2010) 1.23
Genetic associations in peripheral joint osteoarthritis and spinal degenerative disease: a systematic review. Ann Rheum Dis (2007) 1.22
Infection with human T cell leukaemia/lymphoma virus type I in patients attending an antenatal clinic in London. BMJ (1990) 1.22
The public health applications of unlinked anonymous seroprevalence monitoring for HIV in the United Kingdom. Int J Epidemiol (2000) 1.20
Relation between biochemical severity and intelligence in early treated congenital hypothyroidism: a threshold effect. BMJ (1994) 1.20
Cytomegalovirus prevalence in pregnant women: the influence of parity. Arch Dis Child (1992) 1.19
Comparison of methods for analysing cluster randomized trials: an example involving a factorial design. Int J Epidemiol (2003) 1.18
Evaluating novel agent effects in multiple-treatments meta-regression. Stat Med (2010) 1.17
Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses. Health Technol Assess (2007) 1.15
Evidence synthesis assumes additivity on the scale of measurement: response to "Rank reversal in indirect comparisons" by Norton et al. Value Health (2013) 1.15
Behavior disturbance in 8-year-old children with early treated phenylketonuria. Report from the MRC/DHSS Phenylketonuria Register. J Pediatr (1988) 1.14
A generalized weighting regression-derived meta-analysis estimator robust to small-study effects and heterogeneity. Stat Med (2012) 1.14
Risk factors for recent toxoplasma infection in pregnant women in Naples. Epidemiol Infect (1996) 1.14
Bayesian evidence synthesis for a transmission dynamic model for HIV among men who have sex with men. Biostatistics (2011) 1.13
One topical fluoride (toothpastes, or mouthrinses, or gels, or varnishes) versus another for preventing dental caries in children and adolescents. Cochrane Database Syst Rev (2004) 1.13
Use of dried blood spots for the detection and confirmation of HTLV-I specific antibodies for epidemiological purposes. J Clin Pathol (1995) 1.13
Prevalence of toxoplasma IgG among pregnant women in west London according to country of birth and ethnic group. BMJ (1993) 1.12
Uptake of interventions to reduce mother-to-child transmission of HIV in the United Kingdom and Ireland. AIDS (1997) 1.11
An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis. Health Technol Assess (2012) 1.10
Racial differences in rubella immunity among pregnant women. Public Health (1988) 1.09
Evidence synthesis for decision making 1: introduction. Med Decis Making (2013) 1.09
Age-related reference ranges: significance tests for models and confidence intervals for centiles. Stat Med (1994) 1.07
Birth weight and body mass index in childhood, adolescence, and adulthood as predictors of blood pressure at age 36. J Epidemiol Community Health (1993) 1.04
Consistency between direct and indirect trial evidence: is direct evidence always more reliable? Value Health (2011) 1.03
Dietary advice given by a dietitian versus other health professional or self-help resources to reduce blood cholesterol. Cochrane Database Syst Rev (2003) 1.03
Randomized controlled trial of a primary care-based screening program to identify older women with prevalent osteoporotic vertebral fractures: Cohort for Skeletal Health in Bristol and Avon (COSHIBA). J Bone Miner Res (2012) 1.01
Mixture-of-exponentials models to explain heterogeneity in studies of the duration of Chlamydia trachomatis infection. Stat Med (2012) 1.01
Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis. Int J Epidemiol (2001) 1.00
Mother-to-child transmission of HIV: implications of variation in maternal infectivity. AIDS (1998) 0.99
Modelling the costs of paediatric HIV infection and AIDS: comparison of infected children born to screened and unscreened mothers. AIDS (1998) 0.98
A method for the detection and confirmation of antibodies to hepatitis C virus in dried blood spots. J Virol Methods (1997) 0.98
Estimating hepatitis C prevalence in England and Wales by synthesizing evidence from multiple data sources. Assessing data conflict and model fit. Biostatistics (2008) 0.95
Use of evidence in economic decision models: practical issues and methodological challenges. Health Econ (2007) 0.95
Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation. Health Technol Assess (2009) 0.95
Parameterization of treatment effects for meta-analysis in multi-state Markov models. Stat Med (2010) 0.94
Survival time outcomes in randomized, controlled trials and meta-analyses: the parallel universes of efficacy and cost-effectiveness. Value Health (2011) 0.94
Recapture or precapture? Fallibility of standard capture-recapture methods in the presence of referrals between sources. Am J Epidemiol (2014) 0.94
Mixed treatment comparison with multiple outcomes reported inconsistently across trials: evaluation of antivirals for treatment of influenza A and B. Stat Med (2008) 0.93
Validity of indirect comparisons in meta-analysis. Lancet (2007) 0.93
Dose-comparative effects of different statins on serum lipid levels: a network meta-analysis of 256,827 individuals in 181 randomized controlled trials. Eur J Prev Cardiol (2013) 0.93
Evidence synthesis for decision making 6: embedding evidence synthesis in probabilistic cost-effectiveness analysis. Med Decis Making (2013) 0.92
Mapping from disease-specific to generic health-related quality-of-life scales: a common factor model. Value Health (2012) 0.91
Allowing for uncertainty due to missing data in meta-analysis--part 2: hierarchical models. Stat Med (2008) 0.90
Multiple parameter evidence synthesis--a potential solution for when information on drug use and harm is in conflict. Addiction (2013) 0.90
Incorporating correlations between measurements into the estimation of age-related reference ranges. Stat Med (1998) 0.90
Adjusting for publication biases across similar interventions performed well when compared with gold standard data. J Clin Epidemiol (2011) 0.89
Performance of antenatal HIV screening strategies in the United Kingdom. J Med Screen (1998) 0.88
Mixed treatment comparison of repeated measurements of a continuous endpoint: an example using topical treatments for primary open-angle glaucoma and ocular hypertension. Stat Med (2011) 0.87
Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria. Arch Dis Child (1991) 0.85